Nhan Dan – The circulation of seven medicines has been suspended for failing to ensure quality, according to a new announcement by the Department for Medicine Management under the Ministry of Public Health.

These medicines are Loratadine 100 mg, the batch 70549 manufactured by India’s Flamingo pharmaceuticals Ltd; Mycogynax, the batch 08003FN by the Ho Chi Minh City Mekophar Pharmaceutical Chemistry Joint Stock Company; Berberin 10 mg, the batch 02150108 by the Cuu Long Pharmaceutical Joint Stock Company; Melaless Tab, the batch 7002 by the Republic of Korean C-Tri Pharma; Serariben-F lô 050308, the batch 050308 by the Ho Chi Minh City Central Vidipha Pharmaceutical Joint Stock Company; Cetirizine, the batch EV801 by India’s Kausikh Therapeutics (P) Company Ltd; Torilor 10, the batch 136007 by India’s Chethana Drugs and Chemicals (P) Company Ltd.